Pharma Signal combines FDA adverse events, recalls, labels, and SEC filings into decision-ready biotech intelligence. Replace hours of manual research with a single API call.
Answering "Is Ozempic safe?" shouldn't require querying 4 government APIs and parsing 54,000 records.
# One call to answer: "Is Ozempic safe compared to Mounjaro?" curl "https://api.pharma-signal.com/intelligence/v2/compare?drugs=ozempic,mounjaro" \ -H "X-API-Key: your_key" # Response: { "comparison": [ {"drug_name": "OZEMPIC", "serious_rate": 0.449, "death_rate": 0.0158, "company": "NOVO NORDISK"}, {"drug_name": "MOUNJARO", "serious_rate": 0.073, "death_rate": 0.0014, "company": "ELI LILLY"} ], "rankings": {"lowest_serious_rate": "MOUNJARO", "lowest_death_rate": "MOUNJARO"} }
Ask a question about drug safety in plain English.
Ask a question about drug safety in plain English.
Not just data aggregation — derived intelligence that turns raw FDA reports into decisions.
Composite score (0–1) combining adverse events, recalls, and label warnings with explainable breakdown.
Compare 2–5 drugs side by side with automatic rankings on safety metrics.
PRR and ROR analysis detects adverse reactions occurring at disproportionate rates. Evans' criteria classification.
"Ozempic's serious rate is 15% higher than the GLP-1 class average." Automatic therapeutic class benchmarking.
Query by stock ticker, get full drug portfolio with individual risk scores and aggregate exposure.
Claude-powered 3-paragraph safety assessments combining all data sources into natural language.
Monthly time series with anomaly flagging. Know if adverse events are increasing before the market does.
Drug → manufacturer → company → ticker. Cross-source linking that doesn't exist in any public API.
Ask in plain English: "Which AbbVie drugs have the highest risk?" Get a structured, sourced answer.
Start free. Scale as you grow.
AI agents: pay per call via x402 ($0.02–$0.05/query) — no subscription needed.
Explore the API documentation and make your first call in under a minute.